Delivery Order SPE2DR25D1034-SPE2DR26FPV7V
- Not listed
- The Defense Logistics Agency awarded a $34,561.46 delivery order to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count units) on August 27, 2025, with an ultimate completion date of August 28, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, particularly for...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $16,441.71 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count packages) on November 3, 2025, with an ultimate completion date of November 4, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction within...
- The Defense Logistics Agency awarded a delivery order valued at $16,979.99 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count units) on August 27, 2025, with completion targeted for August 28, 2025. This firm fixed-price delivery order represents a non-competitive award under the contractor's existing contract vehicle with DLA. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal...
- The Defense Logistics Agency awarded a delivery order valued at $29,311.53 to AmerisourceBergen Drug Corp for NURTEC ODT 75 MG tablets (8-count units) on April 24, 2025, with an ultimate completion date of April 25, 2025. This firm fixed-price delivery order was awarded without set-aside designation through competitive procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfilled this order as part of its extensive federal...
- The Defense Logistics Agency awarded a delivery order valued at $29,812.77 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count packages) on September 29, 2025, with completion expected by September 30, 2025. This competitively awarded, firm fixed-price contract represents a non-set-aside delivery order for pharmaceutical supply to federal medical procurement needs. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $3,589.84 firm fixed-price delivery order to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count units) on October 20, 2025, with completion due October 21, 2025. This non-competitive delivery order represents a routine pharmaceutical procurement fulfilling federal medical supply requirements. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for military...
- The Defense Logistics Agency awarded a $22,399.17 delivery order to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count packages) on September 17, 2025, with completion expected by September 18, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting...
- The Defense Logistics Agency awarded a delivery order valued at $2,999.35 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count packaging) on July 24, 2025, with completion scheduled for July 25, 2025. This non-set-aside, firm fixed-price delivery order represents a pharmaceutical supply transaction supporting federal medical procurement needs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills the order from its...
- The Defense Logistics Agency awarded a delivery order valued at $21,689.43 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count packages) on November 6, 2025, with completion scheduled for November 7, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the vendor's corporate office located in Conshohocken, Pennsylvania. NURTEC ODT is a prescription migraine treatment medication, reflecting the agency's ongoing pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $6,217.05 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count units) on August 6, 2025, with completion due by August 7, 2025. This firm fixed price, non-set-aside contract represents a direct purchase of pharmaceutical inventory to support federal medical supply requirements. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical...
- SPE2DR25D1034Indefinite Delivery Contract
- SPE2DR25D1034-SPE2DR26FPV7VDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $12,613.79 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count) on November 6, 2025, with an ultimate completion date of November 7, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA Medical Supply Chain. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and related medical commodities. NURTEC ODT is a migraine treatment medication, consistent with the company's extensive portfolio of neurological and specialty pharmaceutical products delivered to federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.6k | 11/6/25 |